The "US POC/Point-of-Care Infectious Disease Market Shares and Segment Forecasts 2017-2021: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers" report has been added to Research and Markets' offering.

This new report provides a comprehensive analysis of the POC infectious disease testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC infectious disease testing market.

Market Segmentation Analysis

  • Review of five POC market segments, including their dynamics, trends, structure, size, growth and major suppliers.
  • Five-year test volume and reagent sales forecasts for major infectious disease tests by market segment

Sales and Market Share Analysis

  • Market shares of major infectious disease diagnostic reagent and instrument suppliers.

Current and Emerging Products

  • Analysis of infectious disease diagnostic tests performed in POC testing locations.
  • Review of leading infectious disease testing analyzers, both currently marketed and those in development, including their operating characteristics, features and selling prices.

Technology Review

  • Emerging technologies and their applications for POC testing.
  • Comprehensive listings of companies developing or marketing coagulation testing technologies and products, by assay.

Competitive Assessments

  • Assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R&D.

Strategic Recommendations

  • Specific opportunities for new infectious disease testing instruments and reagent systems with potentially significant market appeal during the next five years.
  • Design criteria for POC testing products.
  • Alternative business expansion strategies.
  • Potential market entry barriers and risks.

Companies Mentioned

  • Abbott
  • Affymetrix
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Diamedix
  • DiaSorin
  • Eiken Chemical
  • Elitech Group
  • Enzo Biochem
  • Fujirebio
  • Grifols
  • Hologic/Gen-Probe
  • ID Biomedical/GSK
  • Kreat

For more information about this report visit https://www.researchandmarkets.com/research/ccr2l3/us?w=4